(Q51463971)

5 April 2018

title

Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. (English)

1 reference

5 April 2018

0 references

Greany KA

1

1 reference

5 April 2018

Nettleton JA

2

1 reference

5 April 2018

Wangen KE

3

1 reference

5 April 2018

Thomas W

4

1 reference

5 April 2018

Kurzer MS

5

1 reference

5 April 2018

publication date

5 September 2007

1 reference

5 April 2018

European Journal of Clinical Nutrition

published in

1 reference

5 April 2018

volume

62

1 reference

5 April 2018

issue

12

1 reference

5 April 2018

page(s)

1419-1425

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1602885

exact match

0 references

cites work

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

Urinary equol excretion with a soy challenge: influence of habitual diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Time-resolved fluoroimmunoassay for equol in plasma and urine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Production and actions of estrogens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Placental cytochrome P450scc (CYP11A1): comparison of catalytic properties between conditions of limiting and saturating adrenodoxin reductase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Short-term soy and probiotic supplementation does not markedly affect concentrations of reproductive hormones in postmenopausal women with and without histories of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Evidence of a Lack of Effect of a Phytoestrogen Regimen on the Levels of C-Reactive Protein, E-Selectin, and Nitrate in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Homocysteine content of lipoproteins in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Consumption of soy isoflavones does not affect plasma total homocysteine or asymmetric dimethylarginine concentrations in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Homocysteine and risk of cardiovascular disease among postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Controlled substitution of soy protein for meat protein: effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Soy isoflavones modulate immune function in healthy postmenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Time-resolved fluoroimmunoassay of plasma daidzein and genistein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Soy food consumption is associated with lower risk of coronary heart disease in Chinese women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602885

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1602885

1 reference

5 April 2018

PubMed ID

17805230

1 reference

5 April 2018